TREERLY Logo (USPTO, 10.08.2008)
USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke TREERLY wurde als Bildmarke am 10.08.2008 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 02.03.2010 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "IR CANCELLED; US REGISTRATION CANCELLED".
| Markenform | Bildmarke |
| Aktenzeichen | 79065741 |
| Registernummer | 3754883 |
| Anmeldedatum | 10. August 2008 |
| Veröffentlichungsdatum | 15. Dezember 2009 |
| Eintragungsdatum | 02. März 2010 |
Markeninhaber
No. 16 Zhujiang Donglu, Tianhe District, Guangzhou, Guangdong
Markenvertreter
Waren und Dienstleistungen
5
Medicines for human purposes for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; pharmaceutical preparations for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; raw material drugs for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; active pharmaceutical ingredients for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; biochemical drugs for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; biopharmaceuticals for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; dietetic food preparations adapted for medical purposes, namely, Omega-3,vitamins and minerals, herbal extracts; dietetic substances adapted for medical use, namely, Omega-3,vitamins and minerals, herbal extracts; nutritional additives to foodstuffs for medical purposes; injectable solution for medical use for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; solvents for medical use for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer; medical drug tablets for the treatment of cardiovasculars and metabolics diseases, endocrinology diseases, neuroscience diseases, rheumatoid arthritis, gastrointestinal diseases, infectious diseases, anesthesia, respiratory inflammation, immunopathy, vitamin deficiency, bone diseases, cancer
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1379065741